C

Central Coast Neurosciences Research | Erina and Tumbi Umbi

Research site

(Unclaimed)

Location

Suite 2 Level 2 Element Building 200 Central Coast Highway, Erina, New South Wales, Australia

Site insights

Top conditions

Top treatments

Donanemab

Gantenerumab

Bococizumab

LY3002813

RO4602522

Crenezumab

Pegcetacoplan

Aducanumab

BIIB037

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting

Alzheimer Disease

Drug: Donanemab

Drug: Placebo

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The study duration includ...

Enrolling

Alzheimer Disease

Mental Disorders

Drug: Placebo

Drug: Donanemab